JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

VEGFR

VEGFR are receptors for vascular endothelial growth factor and belong to receptor tyrosine kinases.

A2174 Lenvatinib (E7080)

Target: VEGFR|PDGFR|RET

Summary: VEGFR inhibitor

≥21.35 mg/mL
A5057 MGCD-265

Target: VEGFR|c-MET

Summary: Met/Flt/Flk/Ron/Tie-2 inhibitor

≥25.9 mg/mL
A5017 Motesanib Diphosphate (AMG-706)

Summary: VEGFR/ PDGFR/c-Kit/Ret inhibitor

≥28.45 mg/mL
A2974 Foretinib (GSK1363089)

1 Citation

Summary: VEGF and HGF receptor inhibitor

≥31.65 mg/mL
A2633 Brivanib Alaninate (BMS-582664)

Summary: VEGFR2 inhibitor,ATP-competitive

≥22.05 mg/mL
A1778 Vatalanib (PTK787) 2HCl

Target: VEGFR

Summary: Tyrosine kinase receptor inhibitor

≥21 mg/mL
A5331 TSU-68 (SU6668,Orantinib)

Summary: PDGFR/Flk-1/FGFR1 inhibitor,potent and competitive

insoluble in EtOH; insoluble in H2O; ≥15.5 mg/mL
A5467 Ponatinib (AP24534)

1 Citation

Target: VEGFR|PDGFR|Bcr-Abl|FGFR|Src

Summary: pan-BCR-ABL inhibitor,multi-kinase inhibitor

≥53.3 mg/mL
A5760 KRN 633

Summary: VEGFR inhibitor,ATP-competitive

insoluble in EtOH; insoluble in H2O; ≥13.75 mg/mL
A8313 RAF265

Target: Raf|VEGFR

Summary: Multiple intracellular kinases inhibitor

≥25.9 mg/mL